MPO and acute lymphoblastic leukemia: Based on the IHC expression of MPO in the blast cell population of the corresponding BM biopsies, B-ALL patients were classified into two groups: an MPO+ve group comprised of 16 patients (26.7%) and an MPO-ve group including 44 patients (73.3%).